Atlas FDA

Cobas HPV Test

FDA premarket approval P100020/S046 · decided 2019-05-09

Approval details

PMA number
P100020
Supplement
S046
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Cobas HPV Test
Generic name
KIT, DNA DETECTION, HUMAN PAPILLOMAVIRUS
Applicant
Roche Molecular Systems, Inc.
Date received
2019-04-10
Decision date
2019-05-09
Days to decision
29 days
Decision code
OK30
Product code
MAQ
Advisory committee
Microbiology
Expedited review
No
Location
Pleasanton, CA
Statement
Addition of instrumentation qualified to be used to purify oligonucleotides.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
cobas® BV/CV (K260021)Roche Molecular Systems, Inc.2026-07-16
cobas CT/NG for use on the cobas 5800/6800/8800 systems; cobas TV/MG for use on the cobas 5800/6800/8800 systems (K260917)Roche Molecular Systems, Inc.2026-07-08
cobas liat CT/NG/MG nucleic acid test (K253759)Roche Molecular Systems, Inc.2026-05-15
cobas liat CT/NG nucleic acid test (K253756)Roche Molecular Systems, Inc.2026-05-15
cobas liat Bordetella panel nucleic acid test (K243753)Roche Molecular Systems, Inc.2025-11-20
cobas CMV (K252481)Roche Molecular Systems, Inc.2025-11-03
cobas HCV (K252484)Roche Molecular Systems, Inc.2025-11-03
cobas Respiratory 4-flex for use on the cobas 5800/6800/8800 Systems (K243455)Roche Molecular Systems, Inc.2025-07-31